Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Andreas Enger"'
Autor:
Berit Müller‐Meinhard, Nicole Seifert, Johanna Grund, Sarah Reinke, Fatih Yalcin, Helen Kaul, Sven Borchmann, Bastian vonTresckow, Peter Borchmann, Annette Plütschow, Julia Richter, Andreas Engert, Michael Altenbuchinger, Paul J. Bröckelmann, Wolfram Klapper
Publikováno v:
HemaSphere, Vol 8, Iss 6, Pp n/a-n/a (2024)
Abstract Hodgkin–Reed–Sternberg cells (HRSCs) in classic Hodgkin Lymphoma (HL) frequently lack expression of human leukocyte antigen class I (HLA‐I), considered to hamper activation of cytotoxic T cells in the tumor microenvironment (TME). Here
Externí odkaz:
https://doaj.org/article/c00a67a94063469d8ddc58615374db46
Autor:
Paul Bröckelmann, Horst Müller, Sarah Gillessen, Anne Sophie Jacob, Jesko Momotow, Carla Damaschin, Justin Ferdinandus, Xiaoqin Yang, Michael Fuchs, Carsten Kobe, Hans T. Eich, Andreas Engert, Peter Borchmann, Bastian von Tresckow
Publikováno v:
HemaSphere, Vol 7, p e58441b3 (2023)
Externí odkaz:
https://doaj.org/article/2308fff0bc254ac48350e7865eb6ee75
Autor:
Jan-Michel Heger, Julia Mattlener, Laman Mammadova, Sophia Sobesky, Melita Cirillo, Janine Altmüller, Elisabeth Kirst, Sarah Reinke, Wolfram Klapper, Paul J Bröckelmann, Justin Ferdinandus, Roland T Ullrich, Max Freihammer, Sabine Awerkiew, Mia Lohmann, Florian Klein, Peter Nürnberg, Michael Hallek, Andreas Engert, Peter Borchman, Bastian von Tresckow, Sven Borchmann
Publikováno v:
HemaSphere, Vol 7, p e8618132 (2023)
Externí odkaz:
https://doaj.org/article/79607bef1f9e47c8b135e818f59cfcd8
Autor:
Lutz van Heek, Colin Stuka, Helen Kaul, Horst Müller, Jasmin Mettler, Felicitas Hitz, Christian Baues, Michael Fuchs, Peter Borchmann, Andreas Engert, Markus Dietlein, Conrad-Amadeus Voltin, Carsten Kobe
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-8 (2022)
Abstract Background 18F -fluorodeoxyglucose (FDG) positron emission tomography (PET) plays an important role in the staging and response assessment of lymphoma patients. Our aim was to explore the predictive relevance of metabolic tumor volume (MTV)
Externí odkaz:
https://doaj.org/article/dea5bdeca1d44f34bca32af65bf2d19f
Autor:
Lorenz Thurner, Natalie Fadle, Evi Regitz, Sophie Roth, Onur Cetin, Igor Age Kos, Simon Mauro Hess, Julia Bein, Rainer Maria Bohle, Martine Vornanen, Christer Sundström, Laurence de Leval, Enrico Tiacci, Peter Borchmann, Andreas Engert, Viola Poeschel, Gerhard Held, Eva C. Schwarz, Frank Neumann, Klaus-Dieter Preuss, Markus Hoth, Ralf Küppers, Karola Lehman, Martin-Leo Hansmann, Sören L. Becker, Moritz Bewarder, Sylvia Hartmann
Publikováno v:
Haematologica, Vol 108, Iss 12 (2023)
Nodular lymphocyte-predominant Hodgkin lymphoma (NLPHL) is a Hodgkin lymphoma expressing functional B-cell receptors (BCR). Recently, we described a dual stimulation model of IgD+ lymphocyte-predominant cells by Moraxella catarrhalis antigen RpoC and
Externí odkaz:
https://doaj.org/article/5d85a252c48a4566b48ecb1ca09a4eef
Autor:
Michael Oertel, MD, Dominik Hering, MSc, Nina Nacke, MSc, Christopher Kittel, MSc, Kai Kröger, MD, Jan Kriz, MD, Michael Fuchs, MD, Christian Baues, MD, Dirk Vordermark, MD, Rita Engenhart-Cabillic, MD, Klaus Herfarth, MD, Peter Lukas, MD, Heinz Schmidberger, MD, Simone Marnitz, MD, Peter Borchmann, MD, Andreas Engert, MD, Uwe Haverkamp, Hans Theodor Eich, MD
Publikováno v:
Advances in Radiation Oncology, Vol 8, Iss 3, Pp 101169- (2023)
Purpose: Radiation therapy (RT) is an integral part of treatment concepts for early-stage Hodgkin lymphoma. This analysis reports on RT quality in the recent HD16 and 17 trials of the German Hodgkin Study Group (GHSG). Methods and Materials: All RT p
Externí odkaz:
https://doaj.org/article/be482eea6f1c4df195be317ffeda2c0d
Publikováno v:
HemaSphere, Vol 6, Iss 6, p e743 (2022)
Externí odkaz:
https://doaj.org/article/27e93e2c087a413d812030cd89a94f06
Autor:
Thilo, Kober, Andreas, Enger
Publikováno v:
Zeitschrift fur arztliche Fortbildung und Qualitatssicherung. 100(3)
Rising mortality and incidence rates for lymphoma and leukaemia in Germany are of great concern as they have socio-economic and health services implications. Evidence-based medicine (EBM) is one strategy to improve health outcomes of patients with ha
Autor:
Laman Mammadova, Jan-Michel Heger, Julia Mattlener, Sophia Sobesky, Melita Cirillo, Paul J. Bröckelmann, Janine Altmüller, Elisabeth Kirst, Stefanie Kreissl, Mia Lohmann, Peter Nürnberg, Andreas Engert, Peter Borchmann, Bastian Von Tresckow, Sven Borchmann
Publikováno v:
HemaSphere, Vol 6, Pp 17-18 (2022)
Externí odkaz:
https://doaj.org/article/03d66c3bacce433a8541c5bb4bfb7d6b
Autor:
Peter Borchmann, Alden Moccia, Richard Greil, Mark Herzberg, Alexander Fosså, Andreas Hüttmann, Felix Keil, Judith Dierlamm, Valdete Schaub, Mathias Hänel, Urban Novak, Julia Meissner, Johannes Hellmuth, Stephan Mathas, Josée. M. Zijlstra, Andreas Viardot, Bernd Hertenstein, Sonja Martin, Pratush Giri, Stefanie Kreissl, Michael Fuchs, Gundolf Schneider, Andreas Rosenwald, Wolfram Klapper, Hans Theodor Eich, Christian Baues, Michael Hallek, Carsten Kobe, Volker Diehl, Andreas Engert
Publikováno v:
HemaSphere, Vol 6, Pp 1-2 (2022)
Externí odkaz:
https://doaj.org/article/fae1700f06054ad8892e302518d602fa